Pyrotinib Or Lapatinib Plus Capecitabine For Her2+Metastatic Breast Cancer (Phoebe): A Randomized Phase Ill Trial.

Binghe Xu,Min Yan,Fei Ma,Xi-Chun Hu,Ji Feng Feng,Quchang Ouyang,Zhongsheng Tong,Huiping Li,Qingyuan Zhang,Tao Sun,Xian Wang,Yongmei Yin,Ying Cheng,Wei Li,Xiaoyu Zhu,Chunxia Chen,Jianjun Zou

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 31|浏览51

暂无评分

摘要

1003Background: Pyrotinib (an irreversible pan-ErbB inhibitor) plus capecitabine showed clinically meaningful benefits and acceptable tolerability in patients (pts) with HER2+ metastatic breast can...

查看译文

关键词

metastatic breast cancer,breast cancer,lapatinib,capecitabine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要